Cargando…
Tumor cell response to bevacizumab single agent therapy in vitro
BACKGROUND: Angiogenesis represents a highly multi-factorial and multi-cellular complex (patho-) physiologic event involving endothelial cells, tumor cells in malignant conditions, as well as bone marrow derived cells and stromal cells. One main driver is vascular endothelial growth factor (VEGFA),...
Autores principales: | Hein, Melanie, Graver, Shannon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849065/ https://www.ncbi.nlm.nih.gov/pubmed/24059699 http://dx.doi.org/10.1186/1475-2867-13-94 |
Ejemplares similares
-
Human urothelial carcinoma cell response to Sunitinib malate therapy in vitro
por: Wen, Jin, et al.
Publicado: (2015) -
Response to microtubule-interacting agents in primary epithelial ovarian cancer cells
por: Pellicciotta, Ilenia, et al.
Publicado: (2013) -
The impact of body mass index and sociodemographic factors on moderate-to-vigorous physical activity and sedentary behaviors of women with young children: A cross-sectional examination
por: Dinkel, Danae M, et al.
Publicado: (2020) -
Safety and efficacy of bevacizumab combined with R-CHOP regimen in seven Chinese patients with untreated diffuse large B-cell lymphoma
por: Fu, Zhiying, et al.
Publicado: (2014) -
Apoptotic response of malignant rhabdoid tumor cells
por: Nocentini, Silvano
Publicado: (2003)